Ellodi Pharmaceuticals

Ewing Township, United States Founded: 2020 • Age: 6 yrs
Therapeutics for Eosinophilic Esophagitis are developed by Ellodi Pharmaceuticals.

About Ellodi Pharmaceuticals

Ellodi Pharmaceuticals is a Healthcare company based in Ewing Township (United States) founded in 2020. Therapeutics for Eosinophilic Esophagitis are developed by Ellodi Pharmaceuticals. Ellodi Pharmaceuticals offers products and services including APT-1011 and FLUTE 3 Study. Its focus areas include Life Sciences, Rare Diseases, Drugs and GI. Its competitors include Phathom Pharmaceuticals and Lumena Pharma; 2 of its 2 listed competitors have raised funding.

Company details

Ellodi Pharmaceuticals was founded in 2020 and is based in Ewing Township, United States. Focus is placed on the pharmaceutical sector, specifically gastroenterology, where therapeutics for disorders like Eosinophilic Esophagitis are developed. Proprietary orally disintegrating tablets, including APT-1011 and Esomeprazole ODT, are offered to address gastrointestinal conditions and rare chronic allergic inflammatory diseases. Operations center on research and product innovation for these targeted health issues.

  • Headquarters Ewing Township, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ellodipharma.com
  • Social LinkedIn
Operational Areas

Products & Services of Ellodi Pharmaceuticals

Ellodi Pharmaceuticals offers a comprehensive portfolio of products and services, including APT-1011 and FLUTE 3 Study.

APT-1011
Therapy

Novel treatment for Eosinophilic Esophagitis through clinical development

FLUTE 3 Study
Clinical Trial

Research study evaluating therapies for Eosinophilic Esophagitis patients

Competitors of Ellodi Pharmaceuticals

Ellodi Pharmaceuticals has 2 listed competitors in our database, 2 of them funded. They include Phathom Pharmaceuticals and Lumena Pharma.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
phathompharma.com2019Menlo Park, United States$90M113
Therapies for gastrointestinal diseases are developed by Phathom Pharmaceuticals.
lumenapharma.com2011San Diego, United States$71.05M11
Passionately pursuing better treatments for adults and children with rare liver diseases.
Premium access

Detailed competitors of Ellodi Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Rare Diseases

3 companies that operate in the same segment as Ellodi Pharmaceuticals (Rare Diseases) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ellodi Pharmaceuticals

Premium access

Complete news archive for Ellodi Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ellodi Pharmaceuticals

Ellodi Pharmaceuticals was founded in 2020.

Ellodi Pharmaceuticals is headquartered in Ewing Township, United States. It is registered at Ewing Township, New Jersey, United States.

Ellodi Pharmaceuticals was founded in 2020 and is based in Ewing Township, United States. Focus is placed on the pharmaceutical sector, specifically gastroenterology, where therapeutics for disorders like Eosinophilic Esophagitis are developed. Proprietary orally disintegrating tablets, including APT-1011 and Esomeprazole ODT, are offered to address gastrointestinal conditions and rare chronic allergic inflammatory diseases. Operations center on research and product innovation for these targeted health issues.

Ellodi Pharmaceuticals's top competitors include Phathom Pharmaceuticals and Lumena Pharma.

Ellodi Pharmaceuticals offers APT-1011 and FLUTE 3 Study.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available